by Admin Neo Lumina | Jan 19, 2024 | News
Europe to establish regulatory guidance on psychedelics in 2024 The European Medicines Agency (EMA) is set to hold a multi-stakeholder workshop on medical psychedelics in April 2024 to establish regulatory guidelines for the development and therapeutic use of...
by Admin Neo Lumina | Jan 19, 2024 | News
Filament Health Completes The First Export Of Botanical Psilocybin To Australia Reset Mind Sciences Ltd. has received a shipment of PEX010, Filament’s botanical psilocybin drug candidate Vancouver, British Columbia, January 17, 2024 – Filament Health...
by Admin Neo Lumina | Jan 9, 2024 | News
https://www.youtube.com/watch?v=hZAjlikBOk0 Dr. Morello NeoLumina Founder, Director and CEO is an accomplished naturopathic clinician and nutraceutical entrepreneur with over 30 years of experience. We go thru Gaetano’s background, his take on psychedelics,...
by Admin Neo Lumina | Jan 9, 2024 | News
Are Psychedelics the Future of Eating Disorder Treatment? The drugs have been shown to reduce depression and anxiety symptoms and make individuals more flexible in their thinking Sarah Kelley was 14 years old when she first started to feel an intractable need to...
by Admin Neo Lumina | Jan 5, 2024 | News
Psilocybin May Help Some Who Battle Anorexia (HealthDay News) — One dose of the hallucinogenic ingredient in “magic mushrooms” may help some people with anorexia move past their preoccupation with body image, an early study suggests. The study, of...
by Admin Neo Lumina | Jan 5, 2024 | News
Psilocybin Shows Early Promise for Anorexia Nervosa The psychedelic psilocybin may have a role in the treatment of anorexia nervosa (AN), an eating disorder that is notoriously difficult and costly to treat. In a very small phase 1 trial of 10 women with AN, a single...
